Synonyms: 1-(p-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine hydrochloride; GYKI 52466; 471V8NZ5X3; GYKI 52466 dihydrochloride; 1-(p-Aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine hydrochloride; 4-(8-methyl-9h-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-5-yl)aniline; 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine; Benzenamine, 4-(8-methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)-; Benzenamine,4-(8-methyl-9H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-5-yl)-; 4-(8-methyl-9H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d][1,2]diazepin-5-yl)aniline; C17H15N3O2; 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine; GYKI-52466; 4-(8-Methyl-9H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-5-yl)benzenamine; Benzenamine, 4-(8-methyl-9H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-5-yl)-; Gyki Hydrochloride; LFBZZHVSGAHQPP-UHFFFAOYSA-N; Tocris-1454; Lopac-G-119; AC1Q6ZRG; ACMC-20cd27; AC1L1G5T; Lopac0_000631; Gyki-52466; SCHEMBL194854; GTPL4210; ZINC4264; CTK4A1466; GYKI52466; GYKI53784; DTXSID40145500; BCP02050; GYKI-52,466; BDBM50048389; 102771-26-6; PDSP1_001843; PDSP2_001826; AKOS030582785; BCP9000756; CCG-204719; NCGC00015463-01; NCGC00015463-02; NCGC00015463-03; NCGC00015463-04; NCGC00025169-01; GYKI 52466; NCGC00025169-02; 4CA-0617; AJ-08200; AN-16889; LS-28376; LY303070; LS-173287; FT-0729241; A10444; C15040; UNII-471V8NZ5X3; BRD-K24240364-003-02-1; 1-(4-aminophenyl)-4-methyl-7,8 -methylenedioxy-5H-2,3-benzodiazepine; 4-(8-Methyl-9H-1,3-dioxa-6,7-diaza-cyclohepta[f]inden-5-yl)-phenylamine; 4-(8-Methyl-9H-1,3-dioxa-6,7-diaza-cyclohepta[f]inden-5-yl)-phenylamine (GYKI 52466); 4-{13-methyl-4,6-dioxa-11,12-diazatricyclo[7.5.0.0^{3,7}]tetradeca-1(9),2,7,10,12-pentaen-10-yl}aniline; GYKI 52466 hydrochloride; D0A9VO; Gyki 53655; CID3538; GYKI-53655; GYKI 52466 HCl; AR-1F6510; C17-H15-N3-O2; LY 300168; C061950; 10329-75-6; CHEMBL275006; CHEBI:79560;